Systematic review / meta-analysis / 2014
Vitamin D3 supplementation reduced all-cause mortality in randomized trials of adults.
Across 56 randomized trials with 95,286 participants, supplemental vitamin D decreased all-cause mortality (RR 0.97; 95% CI 0.94 to 0.99; P = 0.02). When examined by specific compound, only cholecalciferol yielded a significant reduction in mortality (RR 0.94; 95% CI 0.91 to 0.98; 38 trials), whereas ergocalciferol and active forms showed no significant mortality benefit. Vitamin D3 also lowered cancer mortality (RR 0.88; 95% CI 0.78 to 0.98), but combined use with calcium raised nephrolithiasis risk.
- Study type
- Systematic review and meta-analysis of randomized trials
- Who was studied
- 95,286 adults across 56 randomized clinical trials
- What was measured
- All-cause mortality, cancer mortality, nephrolithiasis, and hypercalcemia
THE PAPER
Vitamin D supplementation for prevention of mortality in adults.
Bjelakovic G, Gluud LL, Nikolova D, Whitfield K, Wetterslev J, Simonetti RG, Bjelakovic M, Gluud C. Cochrane Database Syst Rev, 2014.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.